Source: International Congress 2017 – ME8 Selection criteria in marginal lung cancer candidates



Rating:

Share or cite this content

Citations should be made in the following way:
D. Subotic (Basel, Switzerland). Selection criteria in marginal lung cancer candidates. International Congress 2017 – ME8 Selection criteria in marginal lung cancer candidates

Member's Comments

No comment yet.

Related content which might interest you: ME8 Selection criteria in marginal lung cancer candidates Source: Milan 2017 - Educational material Year: 2017 Lung cancer in COPD Source: Eur Respir Mon 2013; 59: 174-188 Year: 2013 Lung function estimation in patients with lung cancer qualified for surgical treatment Source: Eur Respir J 2006; 28: Suppl. 50, 719s Year: 2006 Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations Source: Eur Respir J 2011; 39: 9-28 Year: 2012 Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations Source: Eur Respir J 2012; 39: 9-28 Year: 2012 Common therapeutic approaches in IPF and lung cancer Source: Research Seminar 2015 Year: 2015 Evolution in the diagnostic approach to lung cancer Source: Virtual Congress 2021 – COVID-19 and management of lung cancer Year: 2021 Validation and comparison of several published prognostic systems for patients with small cell lung cancer Source: Eur Respir J 2011; 38: 657-663 Year: 2011 Proportion of incident lung cancers that would have been eligible for a lung cancer screening program in Australia Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer Year: 2021 Prognostic implications of smoking in patients with advanced lung adenocarcinoma excluding positive mutations Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Staging of primary tracheal cancer as stratification of prognosis is it possible? Source: Annual Congress 2007 - Airway problems: surgical and endoscopic solutions Year: 2007 Potential diagnostic markers in bronquial fluid of patients with non small cell lung cancer (NSCLC) Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 Prognostic relevance of the new lung cancer classification in operable stages Source: International Congress 2014 – The more in-depth classification of lung cancer: relevance for patients and science Year: 2014 Lung function testing for the preoperative evaluation of patients with lung cancer Source: Annual Congress 2003 - Lung function testing for preoperative evaluation in lung cancer patients Year: 2003 Possible predictors of the bronchodilation test response within lung function assessment of patients with operable lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 326s Year: 2005 Validation of a gene-based lung cancer risk test (Respiragene) for high risk smokers: A targeted approach to early detection of lung cancer Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach Year: 2010 Identification of genes with diagnostic and prognostic value in lung cancer. Source: International Congress 2019 – Biology of lung cancer Year: 2019 Survival outcomes of non small cell lung cancer (NSCLC) patients who are suitable for radical treatment at initial presentation Source: Annual Congress 2011 - Quality management for lung cancer patients Year: 2011 The evaluation of lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 323s Year: 2005